Evidence map›Paper›PMID 35227461›Full record

ArticleBiological psychiatry2022

PDZD8 Disruption Causes Cognitive Impairment in Humans, Mice, and Fruit Flies.

Ahmed H Al-Amri, Paul Armstrong, Mascia Amici, Clemence Ligneul, James Rouse, Mohammed E El-Asrag, Andreea Pantiru, Valerie E Vancollie, Hannah W Y Ng, Jennifer A Ogbeta and 15 more

Open access · hybridAbstract read
In one paragraph

Article in Biological psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. LYVAC/PDZD8 is a lysosomal vacuolator.Science (New York, N.Y.) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 6 countries.

Ahmed H Al-AmriSchool of Biomedical Sciences, University of Leeds, Leeds, United Kingdom; Leeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom; National Genetic Centre, Royal Hospital, Muscat, Oman.
Paul ArmstrongSchool of Biomedical Sciences, University of Leeds, Leeds, United Kingdom.
Mascia AmiciSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
Clemence LigneulWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.
James RouseSchool of Biology, University of Leeds, Leeds, United Kingdom.
Mohammed E El-AsragLeeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom; Department of Zoology, Faculty of Science, Benha University, Benha, Egypt; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham.
Andreea PantiruSchool of Biomedical Sciences, University of Leeds, Leeds, United Kingdom.
Valerie E VancollieWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Hannah W Y NgSchool of Biomedical Sciences, University of Leeds, Leeds, United Kingdom.
Jennifer A OgbetaSchool of Biomedical Sciences, University of Leeds, Leeds, United Kingdom.
Kirstie GoodchildSchool of Biomedical Sciences, University of Leeds, Leeds, United Kingdom.
Jacob EllegoodMouse Imaging Centre, Hospital for Sick Children, Toronto, Ontario, Canada.
Christopher J LelliottWellcome Trust Sanger Institute, Hinxton, United Kingdom.
Jonathan G L MullinsInstitute of Life Science, Swansea University, Swansea, United Kingdom.
Amanda BretmanSchool of Biology, University of Leeds, Leeds, United Kingdom.
Ruslan Al-AliCentogene GmbH, Rostock, Germany.
Christian BeetzCentogene GmbH, Rostock, Germany.
Lihadh Al-GazaliDepartment of Paediatrics, College of Medicine & Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Aisha Al ShamsiPediatrics Department, Tawam Hospital, Al Ain, United Arab Emirates.
Jason P LerchWellcome Centre for Integrative Neuroimaging, Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.
Jack R MellorSchool of Physiology, Pharmacology & Neuroscience, University of Bristol, Bristol, United Kingdom.
Abeer Al SayeghGenetics Department, Sultan Qaboos University Hospital, Muscat, Oman.
Manir AliLeeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom.
Chris F InglehearnLeeds Institute of Medical Research, University of Leeds, Leeds, United Kingdom.
Steven J ClapcoteSchool of Biomedical Sciences, University of Leeds, Leeds, United Kingdom. Electronic address: s.j.clapcote@leeds.ac.uk.
University of Leeds · GBCentogene (Germany) · DEUniversity of Bristol · GBUniversity of Oxford · GBWellcome Sanger Institute · GBHospital for Sick Children · CASultan Qaboos University Hospital · OMSwansea University · GBTawam Hospital · AEUnited Arab Emirates University · AE

Funding

Biotechnology and Biological Sciences Research Council BB/R002177/1Biotechnology and Biological Sciences Research Council BB/R019401/1Medical Research Council MC_UP_1502/3Medical Research Council MR/R014736/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/S001719/1Wellcome TrustWellcome Trust 101029/Z/1/Z
6 · The paper itself

Abstract

backgroundThe discovery of coding variants in genes that confer risk of intellectual disability (ID) is an important step toward understanding the pathophysiology of this common developmental disability.

methodsHomozygosity mapping, whole-exome sequencing, and cosegregation analyses were used to identify gene variants responsible for syndromic ID with autistic features in two independent consanguineous families from the Arabian Peninsula. For in vivo functional studies of the implicated gene's function in cognition, Drosophila melanogaster and mice with targeted interference of the orthologous gene were used. Behavioral, electrophysiological, and structural magnetic resonance imaging analyses were conducted for phenotypic testing.

resultsHomozygous premature termination codons in PDZD8, encoding an endoplasmic reticulum-anchored lipid transfer protein, showed cosegregation with syndromic ID in both families. Drosophila melanogaster with knockdown of the PDZD8 ortholog exhibited impaired long-term courtship-based memory. Mice homozygous for a premature termination codon in Pdzd8 exhibited brain structural, hippocampal spatial memory, and synaptic plasticity deficits.

conclusionsThese data demonstrate the involvement of homozygous loss-of-function mutations in PDZD8 in a neurodevelopmental cognitive disorder. Model organisms with manipulation of the orthologous gene replicate aspects of the human phenotype and suggest plausible pathophysiological mechanisms centered on disrupted brain development and synaptic function. These findings are thus consistent with accruing evidence that synaptic defects are a common denominator of ID and other neurodevelopmental conditions.

Indexed as

Cognitive DysfunctionIntellectual DisabilityAdaptor Proteins, Signal TransducingAnimalsConsanguinityDrosophilaDrosophila melanogasterHumansMiceMutationAdaptor Proteins, Signal TransducingPDZD8 protein, humanBrain structureEndoplasmic reticulumIntellectual disabilityLong-term memoryPDZD8Synaptic plasticity

Identifiers

PMID35227461
PMCPMC9302898
OpenAlexW4206202280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.